Board of Directors

Barbara Sahakian, INS PRESIDENT, University of Cambridge

Judy IllesINS PRESIDENT-ELECT, University of British Columbia

Steven Hyman, INS PAST PRESIDENT, Broad Institute of Harvard and MIT

Moheb CostandiNeuroscience Writer

Nita Farahany, Duke Law School

Joe Fins, Weill Cornell Medical College

Mark Frankel,  American Association for the Advancement of Science

Hank Greely, Stanford University

Husseini Manji, Johnson & Johnson

Debra JH Mathews, Johns Hopkins University

Helen Mayberg, Emory University

Ed Rover, Dana Foundation

Ilina Singh, University of Oxford

Dan Stein, University of Cape Town

Paul Root Wolpe, Emory University

Matthew Baum, INS Student Representative, Harvard University


Meet the Recently Elected INS Board Members

We are pleased to introduce six members recently elected to the INS Board:

  • Nita Farahany, Mark Frankel, Ed Rover have been re-elected;
  • Debra JH Mathews and Ilina Singh are new board members, taking the seats of Turhan Canli and Verity Brown. 
  • Dan Stein has been elected for one-year to complete the term of Julian Savulescu who resigned due to the time constraints of an increased schedule in Australia.

New INS Board Members

Debra JH Mathews, PhD, MA, is the Assistant Director for Science Programs at the Johns Hopkins Berman Institute of Bioethics, with a secondary appointment in the Institute of Genetic Medicine, and Associate Professor in the Department of Pediatrics, in the School of Medicine. Dr. Mathews's academic work focuses on ethics and policy issues raised by emerging biotechnologies, with particular focus on genetics, stem cell science, and neuroscience.

Ilina Singh, MA, EdD, Ilina Singh is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Oxford UehiroCentre for Practical Ethics). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families.

Dan Stein, M.D., Ph.D, DPhil is Professor and Chair of the Department of Psychiatry and Mental Health at the University of Cape Town. He works on the psychobiology and management of the anxiety, obsessive-compulsive and related, and trauma and stressor-related disorders. He is interested in philosophical aspects of psychopharmacology, and in neuroethics in the context of global mental health.

Re-elected INS Board Members

Nita Farahany, J.D., Ph.D. is a leading scholar of the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to neuroscience and behavioral genetics. She is the Director of Duke Science & Society, the Duke MA in Bioethics & Science Policy, and a Professor of Law & Philosophy. In 2010, Farahany was appointed by President Obama to the Presidential Commission for the Study of Bioethical Issues, and continues to serve as a member. Nita has served on the INS board since 2012.

Mark Frankel, Ph.D. is Director, Scientific Responsibility, Human Rights and Law Program at the American Association for the Advancement of Science (AAAS). His areas of interest include research ethics, neuroscience and the law, and social responsibilities of scientists. Mark has served on the INS board since 2012, and as a member of the Annual Meeting Program Committee initiated and organized the first public meeting segment of the INS Annual Meeting in 2013, which he did again in 2014.

Edward F. Rover, J.D. is Chairman and CEO of the Dana Foundation. The Dana Foundation is a private philanthropic organization that supports brain research through grants and educates the public about the successes and potential of brain research. Until December 31, 2003, he was a senior partner at White & Case, L.L.P. in New York where he was active in the representation of tax-exempt organizations. Ed has served on the INS board since 2012.

Thanks to the Nominating Committee, who makes an extensive canvas of candidates each year and sends at least two candidates for each open slot to the Board of Directors. The directors make the final selection by secret ballot.

Special thanks to past board members Verity Brown, Turhan Canli and Julian Savulescu for their service on the INS board. Turhan is a founder of the International Neuroethics Society and has served since inception, Savulescu is a long-time active board member, and Brown has been on the board since 2012.

The INS Boards consists of 15 members with staggered 3-year terms, five member's terms expiring each year. In 2016, the terms of the following board members will expire: Hank Greely, Steve Hyman, Judy Illes, Dan Stein (one-year term beginning in 2015 to complete the term of Julian Savulescu) and Paul Root Wolpe.

Governance Statement

1. The 15 members of the Board of Directors will have three-year terms, in staggered order. Terms will end on the last day of February of each year. The Board of Directors should have a diverse membership, broadly reflecting the diversity of the Society's membership, especially with respect to geography. 

2. The Executive Committee will appoint a chair and two additional members to the Nominating Committee. These committee members may be members of the Board of Directors or Executive Committee, but need not be. The other members of the Nominating Committee will be elected by the membership, by electronic means. Only members are eligible and they "run" for the Nominating Committee either by nominating themselves or by being nominated by another member and agreeing to run. Each nomination will need to be seconded by at least one member.

3. The Nominating Committee will be asked to suggest new members of the Board of Directors to replace those who have resigned, let their membership lapse, have had their terms end, or have otherwise left the Board. They should recommend at least twice as many possible members as there are openings and should take into account the needs for balance in the membership of the Board of Directors. They will not be asked to nominate anyone for a particular office. The Executive Committee can add nominees in exceptional circumstances.

4. The Board of Directors will consider these suggestions in appointing new members of the Board or appointing existing members to new terms. It may go outside those suggestions, but it is expected that normally it will not.